Seattle Genetics CEO Clay Siegall's 2019 pay slips 20% to $15M
Seattle Genetics reports 2019 executive compensation
By ExecPay News
Published: April 1, 2020
Seattle Genetics reported fiscal year 2019 executive compensation information on April 1, 2020.
In 2019, six executives at Seattle Genetics received on average a compensation package of $6.4M, a 13% decrease compared to previous year.
Average pay of disclosed executives at Seattle Genetics
Clay B. Siegall, Chief Executive Officer, received $15M in total, which decreased by 20% compared to 2018. 56% of Siegall's compensation, or $8.1M, was in stock awards. Siegall also received $1.9M in non-equity incentive plan, $3.5M in option awards, $963K in salary, as well as $15K in other compensation.
For fiscal year 2019, the median employee pay was $222,352 at Seattle Genetics. Therefore, the ratio of Clay B. Siegall's pay to the median employee pay was 65 to one.
Roger D. Dansey, Chief Medical Officer, received a compensation package of $6.7M, which decreased by 32% compared to previous year. 42% of the compensation package, or $2.8M, was in stock awards.
Robin G. Taylor, Former Chief Commercial Officer, earned $5.2M in 2019.
Todd E. Simpson, Chief Financial Officer, received $4.5M in 2019, which increases by 1% compared to 2018.
Jean I. Liu, General Counsel, earned $4M in 2019, a 5% increase compared to previous year.
Chip R. Romp, Executive Vice President, Commercial U.S, received $3.4M in 2019.
Related executives
Clay Siegall
Seattle Genetics
Chief Executive Officer
Todd Simpson
Seattle Genetics
Chief Financial Officer
Roger Dansey
Seattle Genetics
Chief Medical Officer
Jean Liu
Seattle Genetics
Chief Legal Officer
Robin Taylor
Seattle Genetics
Former Chief Commercial Officer
Chip Romp
Seattle Genetics
Executive Vice President, Commercial U.S
You may also like
Source: SEC filing on April 1, 2020.